London, England, United Kingdom NBGI Ventures is the famous VC, which was founded in 2001. The main office of represented VC is situated in the London. The fund was located in Europe if to be more exact in United Kingdom.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the NBGI Ventures, startups are often financed by Telegraph Hill Partners, Omnes Capital, Bioam Gestion. The meaningful sponsors for the fund in investment in the same round are Omnes Capital, Auriga Partners, Andera Partners. In the next rounds fund is usually obtained by Wellington Partners, Omnes Capital, Auriga Partners.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight EOS Imaging, EPIX Therapeutics, Quanta. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Pharmaceutical, Manufacturing. The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 3 or 4 of the founder, the chance for it to get the investment is meager.
The current fund was established by Aris Constantinides, Spiros Trachanis.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 3 percentage points less often commits exit comparing to other companies. The higher amount of exits for fund were in 2017. The fund is constantly included in less than 2 investment rounds annually. Opposing the other organizations, this NBGI Ventures works on 15 percentage points more the average amount of lead investments. The top activity for fund was in 2010.
Related Funds
Funds with similar focus
| Fund Name | Location |
| 57 Stars | District of Columbia, United States, Washington |
| Axeleo | France, Ile-de-France, Paris |
| Blackbox | California, San Francisco, United States |
| CHANEL | France, Ile-de-France, Neuilly-sur-seine |
| codecentric AG | Düsseldorf, Germany, Nordrhein-Westfalen |
| Fairview Health Services | Minneapolis, Minnesota, United States |
| Flexible Funding | - |
| Heshi Jiye | China, Qingpu, Shanghai |
| Incepta Group | England, London, United Kingdom |
| JG OE Investments LLC | Dallas, Texas, United States |
| Link and Motivation | Hokkaido Prefecture, Japan, Sapporo |
| LS Polaris Innovation Fund | - |
| Nanotech Partners | Japan, Tokyo |
| Nazer Group | Jeddah, Makkah, Saudi Arabia |
| Sunshine Venture Capital | Beijing, Beijing, China |
| Superangel | Estonia, Harjumaa, Tallinn |
| Surveyor Capital | Chicago, Illinois, United States |
| Tririver Capital | China, Shanghai |
| Yingchuang Dehong | Chengdu, China, Sichuan |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Quanta | $36M | 03 Nov 2014 | England | ||
CellNovo | $41M | 04 Feb 2011 | Allerdale, England, United Kingdom | ||
SuperSonic Imagine | $40M | 29 Nov 2010 | Provence-Alpes-Côte d'Azur | ||
Symetis | $25M | 08 Oct 2010 | Vaud, Switzerland | ||
Reverse Medical | $14M | 07 Apr 2010 | Irvine, California, United States | ||
EPIX Therapeutics | $5M | 11 Jan 2010 | Laguna Beach, California, United States | ||
Quanta | $14M | 01 Nov 2009 | England | ||
SuperSonic Imagine | $23M | 23 Oct 2008 | Provence-Alpes-Côte d'Azur | ||
SuperSonic Imagine | $11M | 01 Mar 2006 | Aix-en-Provence, Provence-Alpes-Côte d'Azur, France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Quanta | $36M | 03 Nov 2014 | England | ||
CellNovo | $41M | 04 Feb 2011 | Allerdale, England, United Kingdom | ||
SuperSonic Imagine | $40M | 29 Nov 2010 | Provence-Alpes-Côte d'Azur | ||
Symetis | $25M | 08 Oct 2010 | Vaud, Switzerland | ||
Reverse Medical | $14M | 07 Apr 2010 | Irvine, California, United States | ||
EPIX Therapeutics | $5M | 11 Jan 2010 | Laguna Beach, California, United States | ||
Quanta | $14M | 01 Nov 2009 | England | ||
SuperSonic Imagine | $23M | 23 Oct 2008 | Provence-Alpes-Côte d'Azur | ||
SuperSonic Imagine | $11M | 01 Mar 2006 | Aix-en-Provence, Provence-Alpes-Côte d'Azur, France |
